Alirocumab’s ODYSSEY continues: Efficacy unaffected by insulin, beats fenofibrateSeptember 15, 2017DiabetesLipid Disorders
New data prompt update to ACC guidance on nonstatin LDL loweringSeptember 14, 2017Lipid DisordersCAD & AtherosclerosisPeripheral Vascular DisordersPreventive Care
Most type 2 diabetes patients skipping metformin as first-line therapySeptember 13, 2017DiabetesLipid Disorders
Metabolically healthy obese still at elevated cardiovascular riskSeptember 11, 2017Lipid DisordersPreventive CareCAD & AtherosclerosisPeripheral Vascular DisordersHypertensionHeart Failure
Recent upturn seen in stroke death rateSeptember 7, 2017StrokeAcute Coronary SyndromesPeripheral Vascular DisordersLipid Disorders
Dr. Clyde Yancy: CANTOS wows, opens new therapeutic avenuesAugust 29, 2017CAD & AtherosclerosisLipid Disorders
VIDEO: Anacetrapib doubles HDL, but patients gain from its modest LDL cutAugust 29, 2017Lipid DisordersCAD & AtherosclerosisPeripheral Vascular Disorders
CANTOS sings of novel strategy for cardiovascular, cancer preventionAugust 28, 2017CAD & AtherosclerosisAcute Coronary SyndromesLipid DisordersPediatricsPeripheral Vascular DisordersThrombosis
VIDEO: Inflammation’s role in atherosclerosis confirmed in CANTOSAugust 27, 2017Lipid DisordersCAD & AtherosclerosisThrombosis
